About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Cardiology and Nephrology Clinical Development
›
top-articles
Cardiology and Nephrology Clinical Development
21
(top 2%)
papers
709
(top 2%)
citations
12
(top 2%)
h
-index
17
(top 2%)
g
-index
21
all documents
845
doc citations
226
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
European Heart Journal
2022
341
2
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial
Journal of the American Society of Nephrology: JASN
2022
89
3
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Journal of the American College of Cardiology
2021
74
4
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy
Kidney International Reports
2022
73
5
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
Nephrology Dialysis Transplantation
2022
50
6
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by
GLP‐1RA
treatment: A subgroup analysis from the
FIDELIO‐DKD
trial
Diabetes, Obesity and Metabolism
2022
41
7
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory
post hoc
analyses from FIDELIO-DKD compared to reported CREDENCE results
Nephrology Dialysis Transplantation
2022
32
8
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Hypertension
2022
24
9
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the
FIDELIO‐DKD
trial
European Journal of Heart Failure
2022
23
10
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
Journal of Hypertension
2023
23
11
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
Diabetes Care
2022
20
12
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease
CKJ: Clinical Kidney Journal
2023
19
13
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
European Heart Journal - Cardiovascular Pharmacotherapy
2023
12
14
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes
Clinical Journal of the American Society of Nephrology: CJASN
2023
12
15
Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
European Heart Journal - Cardiovascular Pharmacotherapy
2022
6
16
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of
HbA1c
at baseline,
HbA1c
variability, diabetes duration and insulin use at baseline
Diabetes, Obesity and Metabolism
2023
4
17
FC 090EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D
Nephrology Dialysis Transplantation
2021
2
18
POS-350 FINERENONE IN MILD TO SEVERE CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES: THE FIDELITY PRESPECIFIED POOLED ANALYSIS
Kidney International Reports
2022
0
19
MO198: Outcomes with Finerenone in Patients with Stage 4 Chronic Kidney Disease and Type 2 Diabetes: A Fidelity Subgroup Analysis
Nephrology Dialysis Transplantation
2022
0
20
Finerenone and Cardiorenal Outcomes by History of Cardiovascular Disease in Patients with Type 2 Diabetes: Fidelity Analyses
American Heart Journal
2022
0
21
Finerenone in Mild to Severe Chronic Kidney Disease and Type 2 Diabetes: A Fidelity Subgroup Analysis in Patients with Heart Failure
American Heart Journal
2022
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.